Company Filing History:
Years Active: 1989
Title: The Innovations of Robert N McEwan
Introduction
Robert N McEwan is a notable inventor based in Richland Township, MI (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostate cancer. His work has led to advancements that are crucial for early diagnosis and treatment.
Latest Patents
Robert N McEwan holds a patent for a monoclonal antibody to prostate secretory protein. This patent includes hybridomas for producing monoclonal antibodies against human prostate secretory protein (PSP15). The anti-PSP15 monoclonal antibodies, along with their fragments and derivatives, are designed for use in diagnostics. These antibodies are monospecific, bind to protein A, and belong to the IgM class of immunoglobulins. They are particularly useful for detecting human prostate cancer cells, providing a vital tool for early diagnosis.
Career Highlights
Throughout his career, Robert has been associated with The Upjohn Company, where he has contributed to various research initiatives. His work has been instrumental in developing diagnostic tools that enhance the understanding and treatment of prostate cancer.
Collaborations
Robert has collaborated with Donald Bainbridge Carter, furthering research and development in the field of immunology and cancer diagnostics.
Conclusion
Robert N McEwan's innovations in monoclonal antibodies have paved the way for improved diagnostic methods in prostate cancer detection. His contributions continue to impact the medical field positively.